Recruiting
Phase 2

Sponsor:

Takeda

Code:

NCT02616302

Conditions

Gastroesophageal Reflux Disease (GERD)

Eligibility Criteria

Sex: All

Age: 2 - 11

Healthy Volunteers: Not accepted

Interventions

Dexlansoprazole

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Takeda on 2024-11-13.